Friday 29 May 2020
Home      All news      Contact us      India
oneindia.com - 7 days ago

UK begins anti-malaria drug trial to test COVID-19 prevention

London, May 21: The first UK frontline National Health Service (NHS) worker will be enrolled as a participant into COPCOV, the largest multinational interventional clinical study into the prevention of COVID-19 using the investigational medicine hydroxychloroquine. Enrolment begins on


Latest News
Hashtags:   

begins

 | 

malaria

 | 

trial

 | 

COVID

 | 

prevention

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources